IL203073A0 - Modified growth hormone polypeptides - Google Patents

Modified growth hormone polypeptides

Info

Publication number
IL203073A0
IL203073A0 IL203073A IL20307309A IL203073A0 IL 203073 A0 IL203073 A0 IL 203073A0 IL 203073 A IL203073 A IL 203073A IL 20307309 A IL20307309 A IL 20307309A IL 203073 A0 IL203073 A0 IL 203073A0
Authority
IL
Israel
Prior art keywords
growth hormone
modified growth
hormone polypeptides
polypeptides
modified
Prior art date
Application number
IL203073A
Other languages
English (en)
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterion Ltd filed Critical Asterion Ltd
Publication of IL203073A0 publication Critical patent/IL203073A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL203073A 2007-10-10 2009-12-31 Modified growth hormone polypeptides IL203073A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides
PCT/GB2008/003056 WO2009047474A2 (en) 2007-10-10 2008-09-10 Modified growth hormone polypeptides

Publications (1)

Publication Number Publication Date
IL203073A0 true IL203073A0 (en) 2010-11-30

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
IL203073A IL203073A0 (en) 2007-10-10 2009-12-31 Modified growth hormone polypeptides

Country Status (17)

Country Link
US (2) US8273552B2 (enExample)
EP (2) EP2886553A1 (enExample)
JP (1) JP5697983B2 (enExample)
KR (1) KR20100067686A (enExample)
CN (1) CN101932600B (enExample)
AR (1) AR068038A1 (enExample)
AU (1) AU2008309386A1 (enExample)
BR (1) BRPI0818639A2 (enExample)
CA (1) CA2701369A1 (enExample)
DK (1) DK2209798T3 (enExample)
ES (1) ES2532600T3 (enExample)
GB (1) GB0719818D0 (enExample)
IL (1) IL203073A0 (enExample)
MX (1) MX2010003892A (enExample)
RU (1) RU2471808C2 (enExample)
TW (1) TW200918098A (enExample)
WO (1) WO2009047474A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) * 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
DE851925T1 (de) * 1995-09-21 2003-08-14 Genentech Inc., San Francisco Varianten des menschlichen wachstumshormons
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
EP1290170A2 (en) * 2000-06-16 2003-03-12 Asterion Limited Binding agents: chimeric ligand/receptor proteins
EP1456398B1 (en) * 2001-11-21 2011-05-11 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
GB2389115B (en) * 2001-12-14 2005-03-16 Asterion Ltd Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
US7625998B2 (en) * 2003-04-09 2009-12-01 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
US20090221477A1 (en) * 2004-07-26 2009-09-03 Asterion Limited Linkers
GB0717985D0 (en) * 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
JP2011512134A (ja) * 2008-02-19 2011-04-21 アステリオン・リミテッド 修飾リンカー

Also Published As

Publication number Publication date
RU2471808C2 (ru) 2013-01-10
AR068038A1 (es) 2009-10-28
RU2010103159A (ru) 2011-11-20
EP2886553A1 (en) 2015-06-24
US20120322735A1 (en) 2012-12-20
KR20100067686A (ko) 2010-06-21
TW200918098A (en) 2009-05-01
WO2009047474A2 (en) 2009-04-16
MX2010003892A (es) 2010-05-17
GB0719818D0 (en) 2007-11-21
DK2209798T3 (en) 2015-03-23
EP2209798B1 (en) 2014-12-31
ES2532600T3 (es) 2015-03-30
CN101932600B (zh) 2014-05-28
EP2209798A2 (en) 2010-07-28
BRPI0818639A2 (pt) 2015-04-07
WO2009047474A3 (en) 2010-09-02
JP5697983B2 (ja) 2015-04-08
CA2701369A1 (en) 2009-04-16
CN101932600A (zh) 2010-12-29
AU2008309386A1 (en) 2009-04-16
JP2011507487A (ja) 2011-03-10
US8273552B2 (en) 2012-09-25
US20100197589A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
IL221062A0 (en) Stitched polypeptides
GB0721686D0 (en) Polypeptides
IL195156A0 (en) Stabilized insulin-like growth factor polypeptides
PT3118220T (pt) Proteína
PT2765139T (pt) Polipéptidos natriuréticos
ZA200906699B (en) Insecticidal proteins
IL201791A (en) Interferon-adapted polypeptides in the cell
ZA201000283B (en) Reinigung pegylierter polypeptide
IL202225A0 (en) Growth hormone fusion proteins
GB0723712D0 (en) Peptides
ZA200809384B (en) Stabilized insulin-like growth factor polypeptides
EP2180205A4 (en) ENERGY ABSORPTION MATERIAL
EP2123666A4 (en) PEPTIDE
EP2133090A4 (en) GROWTH HORMONE SECRETION STIMULATOR
GB0719231D0 (en) Protein
IL203073A0 (en) Modified growth hormone polypeptides
GB0712302D0 (en) Chrondroitinase polypeptides
GB0703945D0 (en) Peptide
GB0809659D0 (en) Polypeptides
GB0623539D0 (en) Polypeptides
GB0708529D0 (en) Peptide standards
HK1146066A (en) Modified growth hormone polypeptides
EP2204379A4 (en) POLYPEPTIDE COMPOUND
GB0720563D0 (en) Protein
GB0600114D0 (en) Growth hormone variations